Novel Imaging Techniques in Barrett's Esophagus
Completed · Not applicable
Conditions studied: Barrett Esophagus, Gastroesophageal Reflux
In brief
Primary Aim: In patients with endoscopically suspected BE, compared to standard endoscopy, novel techniques (NBI and AFI) with target biopsies will * Detect more patients with intestinal metaplasia * Detect more areas of high grade dysplasia * Require fewer biopsies and a shorter time for procedure completion Secondary Aim: * Compare the yield of high-grade dysplasia(HGD)using NBI/AFI versus standard endoscopy with biopsy. * Compare the number of biopsies and procedure times for NBI/AFI versus standard endoscopy with biopsy. * Compare the inter-observer variability in classifying different mucosal and vascular patterns observed by NBI/AFI using kappa statistics.
Key facts
- Study ID
- NCT00576498
- Run by
- Midwest Biomedical Research
- People needed
- 130
- Starts
- 2005-10-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2012-10-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with suspected Barrett's esophagus on endoscopy
- Age > 18 years
- Ability to provide written informed consent
You may not qualify if…
- Presence of erosive esophagitis
- Visible nodules, lesions within Barrett's esophagus segment
- Endoscopist aware of biopsy results
- Inability to obtain biopsies due to anticoagulation or varices
Where it is running
- Veterans Affairs Medical Center — Kansas City, Missouri, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
- Academisch Medisch Centrum-Universiteit van Amsterdam (AMC-UvA) — Amsterdam, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.